ArticleCancers2021

Survival of Patients with Epidermal Growth Factor Receptor-Mutated Metastatic Non-Small Cell Lung Cancer Treated beyond the Second Line in the Tyrosine Kinase Inhibitor Era.

Valéry Refeno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.